California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program

Rhea-AI Summary

The California Department of Health Care Services (DHCS) has selected Pear Therapeutics to implement the Recovery Incentives: California’s Contingency Management Program aiming to treat Medi-Cal members with stimulant use disorder. This pilot program will span 24 weeks and cover participants from 24 counties, followed by up to six months of recovery support. Pear will manage the electronic tracking and distribution of incentives. The initiative is viewed as a crucial step in expanding access to behavioral treatments for stimulant use disorders in California.

Positive

• Selected by DHCS to implement a significant pilot program aimed at treating stimulant use disorder.
• The program will support Medi-Cal members in 24 counties, enhancing access to behavioral treatment.

Negative

• None.

• The California Department of Health Care Services (DHCS) selected Pear Therapeutics to track and distribute incentives for the groundbreaking Recovery Incentives: California’s Contingency Management Program, to treat Medi-Cal members with stimulant use disorder
  
  
  
  
• DHCS intends to use the pilot as a basis for informing the design and implementation of a statewide contingency management benefit through the Drug Medi-Cal Organized Delivery System, pending budgetary and statutory authority

BOSTON--(BUSINESS WIRE)-- The California Department of Health Care Services (DHCS) has selected Pear Therapeutics, Inc. (Nasdaq: PEAR), a leader in developing and commercializing software-based medicines, to support the implementation of the Recovery Incentives: California’s Contingency Management Program. Contingency management is an evidence-based, cost-effective treatment that provides motivational incentives to treat individuals living with stimulant use disorder and support their path to recovery.

The pilot program will allow eligible Medi-Cal members, across 24 counties in California, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services. Pear Therapeutics will partner with DHCS to deliver, implement, and manage this program, specifically by managing the electronic tracking and distribution of incentives to Medi-Cal members who participate in this contingency management pilot.

“We applaud California’s DHCS for taking this important step to expand access to behavioral treatment to address the stimulant use disorder crisis that persists in California,” said Julia Strandberg, Chief Commercial Officer of Pear Therapeutics. “By working together, we will implement an innovative program that will reinforce individual positive behavioral change consistent with meeting treatment goals.”

As stimulant use disorder continues to be pervasive across the United States, Pear Therapeutics is committed to providing individuals across the country with access to its innovative treatment options.

About Pear Therapeutics

Pear Therapeutics, Inc. is a leader in developing and commercializing software-based medicines, called prescription digital therapeutics. Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. For more information, visit Pear at www.peartherapeutics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005160/en/

Media and Investors:

Meara Murphy

Senior Director, Corporate Communications

meara.murphy@peartherapeutics.com

Source: Pear Therapeutics, Inc.

FAQ

What is the Recovery Incentives program by Pear Therapeutics?

The Recovery Incentives program is a pilot initiative selected by the California DHCS to treat Medi-Cal members with stimulant use disorder through contingency management.

How long will the Pear Therapeutics pilot program last?

The pilot program will last for 24 weeks, followed by at least six months of recovery support services.

Which counties in California are involved in Pear Therapeutics' program?

The program will include participants from 24 counties in California.

What role does Pear Therapeutics play in the Recovery Incentives program?

Pear Therapeutics is responsible for managing the electronic tracking and distribution of incentives for participants in the program.

How does the contingency management approach work in this program?

The contingency management approach offers motivational incentives to individuals with stimulant use disorder, encouraging positive behavioral changes.